MedWatch

New device to drive growth, says William Demant deputy

The launch of the new hearing device Oticon Opn is going to drive growth for William Demant in years to come, not least in the US. But the Danish manufacturer is finding it difficult to make an impact in another market for which it had high hopes, says deputy CEO Søren Nielsen in an interview with MedWatch.

Foto: Niles Hougaard/POLFOTO/arkiv

One aspect overshadowed all the others for hearing device manufacturer William Demant in the first six months of the year: The launch of its newest device Oticon Opn, which entered the market in late Q2.

“The main thing giving me joy in the first half of the year is the launch of Oticon Opn and the fantastic reception it has enjoyed in the market. Unfortunately we launched it a bit later than we would have liked, so we had a relatively short sales window in H1. Consequently, the commercial result is perhaps not as some would have hoped. But we have said all along that things will pick up pace in H2, and we still believe that,” says deputy CEO, Søren Nielsen, in an interview with MedWatch.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier